Covestor’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-163
Closed -$3K 2262
2025
Q1
$3K Hold
163
﹤0.01% 1774
2024
Q4
$4K Buy
163
+29
+22% +$558 ﹤0.01% 1750
2024
Q3
$2K Hold
134
﹤0.01% 1796
2024
Q2
$2K Hold
134
﹤0.01% 1836
2024
Q1
$1K Hold
134
﹤0.01% 1928
2023
Q4
$1K Buy
134
+24
+22% +$187 ﹤0.01% 1939
2023
Q3
$1K Hold
110
﹤0.01% 1907
2023
Q2
$1K Buy
+110
New +$641 ﹤0.01% 1919

Other funds holding CLBT

Covestor's CLBT Position: Q2 2025 in Review

Covestor sold out of Cellebrite (CLBT) in Q2 2025, closing a stake of 163 shares — an estimated $3K sold.

Covestor first reported a position in CLBT in Q2 2023 and held it in 8 quarters. The position peaked at $4K in Q4 2024. 209 funds tracked by Wall St. Rank hold CLBT as of Q2 2025.

  • Covestor reported no remaining Cellebrite position as of Q2 2025 after selling out during the quarter.
  • Covestor sold 163 Cellebrite shares in Q2 2025, an estimated $3K.
  • Covestor first reported a position in Cellebrite in Q2 2023 and held it in 8 quarters.
  • Covestor's Cellebrite position peaked at $4K in Q4 2024.
  • 209 funds tracked by Wall St. Rank held Cellebrite as of Q2 2025.

Based on Covestor's 13F filing for Q2 2025, filed 11 Aug 2025.